3 results on '"Tian, Jian-Bo"'
Search Results
2. Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China.
- Author
-
Tang H, Tian JB, Dong JW, Tang XT, Yan ZY, Zhao YY, Xiong F, Sun X, Song CX, Xiang CG, Tu C, Lei CT, Liu J, Su H, Huang J, Qiu Y, Miao XP, and Zhang C
- Subjects
- COVID-19, China epidemiology, Comorbidity, Coronavirus Infections epidemiology, Cross-Sectional Studies, Female, Humans, Kidney Failure, Chronic epidemiology, Male, Middle Aged, Pandemics, Pneumonia, Viral epidemiology, Prevalence, Retrospective Studies, SARS-CoV-2, Serologic Tests methods, Tomography, X-Ray Computed, Antibodies, Viral analysis, Betacoronavirus immunology, Coronavirus Infections diagnosis, Kidney Failure, Chronic therapy, Pneumonia, Viral diagnosis, Renal Dialysis
- Abstract
Rationale & Objective: Patients receiving maintenance hemodialysis (MHD) are highly vulnerable to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The current study was designed to evaluate the prevalence of SARS-CoV-2 infection based on both nucleic acid testing (NAT) and antibody testing in Chinese patients receiving MHD., Study Design: Cross-sectional study., Setting & Participants: From December 1, 2019, to March 31, 2020, a total of 1,027 MHD patients in 5 large hemodialysis centers in Wuhan, China, were enrolled. Patients were screened for SARS-CoV-2 infection by symptoms and initial computed tomography (CT) of the chest. If patients developed symptoms after the initial screening was negative, repeat CT was performed. Patients suspected of being infected with SARS-CoV-2 were tested with 2 consecutive throat swabs for viral RNA. In mid-March 2020, antibody testing for SARS-CoV-2 was obtained for all MHD patients., Exposure: NAT and antibody testing results for SARS-CoV-2., Outcomes: Morbidity, clinical features, and laboratory and radiologic findings., Analytical Approach: Differences between groups were examined using t test or Mann-Whitney U test, comparing those not infected with those infected and comparing those with infection detected using NAT with those with infection detected by positive serology test results., Results: Among 1,027 patients receiving MHD, 99 were identified as having SARS-CoV-2 infection, for a prevalence of 9.6%. Among the 99 cases, 52 (53%) were initially diagnosed with SARS-CoV-2 infection by positive NAT; 47 (47%) were identified later by positive immunoglobulin G (IgG) or IgM antibodies against SARS-CoV-2. There was a spectrum of antibody profiles in these 47 patients: IgM antibodies in 5 (11%), IgG antibodies in 35 (74%), and both IgM and IgG antibodies in 7 (15%). Of the 99 cases, 51% were asymptomatic during the epidemic; 61% had ground-glass or patchy opacities on CT of the chest compared with 11.6% among uninfected patients (P<0.001). Patients with hypertensive kidney disease were more often found to have SARS-CoV-2 infection and were more likely to be symptomatic than patients with another primary cause of kidney failure., Limitations: Possible false-positive and false-negative results for both NAT and antibody testing; possible lack of generalizability to other dialysis populations., Conclusions: Half the SARS-CoV-2 infections in patients receiving MHD were subclinical and were not identified by universal CT of the chest and selective NAT. Serologic testing may help evaluate the overall prevalence and understand the diversity of clinical courses among patients receiving MHD who are infected with SARS-CoV-2., (Copyright © 2020 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
3. Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.
- Author
-
Xiong F, Tang H, Liu L, Tu C, Tian JB, Lei CT, Liu J, Dong JW, Chen WL, Wang XH, Luo D, Shi M, Miao XP, and Zhang C
- Subjects
- Age Factors, Aged, COVID-19, Chi-Square Distribution, China epidemiology, Comorbidity, Coronavirus Infections diagnosis, Coronavirus Infections therapy, Female, Humans, Kidney Failure, Chronic diagnosis, Kidney Failure, Chronic therapy, Male, Middle Aged, Pandemics, Pneumonia, Viral diagnosis, Pneumonia, Viral therapy, Prevalence, Radiography, Thoracic methods, Renal Dialysis statistics & numerical data, Retrospective Studies, Risk Assessment, Sex Factors, Statistics, Nonparametric, Survival Analysis, Tomography, X-Ray Computed methods, Coronavirus Infections epidemiology, Disease Susceptibility epidemiology, Kidney Failure, Chronic epidemiology, Pneumonia, Viral epidemiology, Registries, Renal Dialysis methods
- Abstract
Background: Reports indicate that those most vulnerable to developing severe coronavirus disease 2019 (COVID-19) are older adults and those with underlying illnesses, such as diabetes mellitus, hypertension, or cardiovascular disease, which are common comorbidities among patients undergoing maintenance hemodialysis. However, there is limited information about the clinical characteristics of hemodialysis patients with COVID-19 or about interventions to control COVID-19 in hemodialysis centers., Methods: We collected data retrospectively through an online registration system that includes all patients receiving maintenance hemodialysis at 65 centers in Wuhan, China. We reviewed epidemiologic and clinical data of patients with laboratory-confirmed COVID-19 between January 1, 2020 and March 10, 2020., Results: Of 7154 patients undergoing hemodialysis, 154 had laboratory-confirmed COVID-19. The mean age of the 131 patients in our analysis was 63.2 years; 57.3% were men. Many had underlying comorbidities, with cardiovascular disease (including hypertension) being the most common (68.7%). Only 51.9% of patients manifested fever; 21.4% of infected patients were asymptomatic. The most common finding on chest computed tomography (CT) was ground-grass or patchy opacity (82.1%). After initiating comprehensive interventions-including entrance screening of body temperature and symptoms, universal chest CT and blood tests, and other measures-new patients presenting with COVID-19 peaked at 10 per day on January 30, decreasing to 4 per day on February 11. No new cases occurred between February 26 and March 10, 2020., Conclusions: We found that patients receiving maintenance hemodialysis were susceptible to COVID-19 and that hemodialysis centers were high-risk settings during the epidemic. Increasing prevention efforts, instituting universal screening, and isolating patients with COVID-19 and directing them to designated hemodialysis centers were effective in preventing the spread of COVID-19 in hemodialysis centers., (Copyright © 2020 by the American Society of Nephrology.)
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.